Baxter Win Gives Drugmakers A Leg Up In NJ Warning Suits

Law360, New York (August 27, 2012, 8:44 PM EDT) -- A New Jersey federal judge ruled last week that a woman's doctor would have prescribed her a Baxter Healthcare Corp. drug even if a warning label described its clotting risks in more detail, handing drugmakers an important victory in an undeveloped area of law in the pharma-heavy state, attorneys say.

Plaintiff Evageline Baker received Baxter-made heparin, an anti-clotting drug, as part of treatment for a triple coronary bypass. She soon developed heparin-induced thrombocytopenia and thrombosis, or HITT, suffering blood clots and gangrene in one of her...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

BAKER v. APP PHARMACEUTICALS, LLC et al


Case Number

3:09-cv-05725

Court

New Jersey

Nature of Suit

Personal Inj. Prod. Liability

Judge

Joel A. Pisano

Date Filed

November 9, 2009

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.